The pathophysiological significance of Parkin Ser65 phosphorylation in mammals is ultimately substantiated by the clinical discovery of two unrelated patients with relatively early onset PD harbouring a homozygous PARK2 Ser65Asn (ParkinS65N) mutation. The gene discussed is PRKN; the disease is Parkinson disease.